M. Szász
发表
A. Lánczky,
J. Budczies,
B. Győrffy,
2013,
Breast Cancer Research and Treatment.
G. Szigeti,
A. Szász,
M. Szász,
2020
.
H. Kwon,
G. Marko‐Varga,
J. Kim,
2020,
Cancers.
H. Kwon,
J. Malm,
G. Marko‐Varga,
2020,
Proteomics.
H. Kwon,
J. Malm,
G. Marko‐Varga,
2018,
Clinical and Translational Medicine.
G. Szigeti,
A. Szász,
M. Szász,
2020,
International Journal of Clinical Medicine.
H. Reis,
C. Niedworok,
T. Szarvas,
2016,
Urologic oncology.
H. Klingler,
T. Szarvas,
P. Nyirády,
2020
.
H. Bojar,
A. Baierl,
T. Bakács,
2020,
Cancer Immunology, Immunotherapy.
O. Menyhárt,
G. Munkácsy,
M. Szász,
2015,
Breast Cancer.
T. Bakács,
R. Moss,
M. Szász,
2019,
Scandinavian journal of immunology.
S. Ghaem-Maghami,
Z. Takáts,
M. Paraskevaidi,
2020,
Proceedings of the National Academy of Sciences.
B. Hadaschik,
I. Kovalszky,
J. Tímár,
2020,
Pathology & Oncology Research.
B. Ács,
J. Moldvay,
B. Szekely,
2017,
Virchows Archiv.
J. Kulka,
M. Szász,
2011
.
A. Szász,
O. Szász,
C. Minnaar,
2017
.
Z. Szallasi,
A. Eklund,
M. Krzystanek,
2013,
Thrombosis and Haemostasis.
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
I. O. Ellis,
Andrew R. Green,
E. A. Rakha,
2016,
Breast Cancer Research and Treatment.
M. Szász,
Z. Komka,
J. Elek,
2019
.
M. Szász,
2012,
Magyar onkologia.
The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
H. Moch,
C. Leo,
Z. Varga,
2013,
BMC Cancer.
The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
C. Leo,
Z. Varga,
J. Kulka,
2013,
BMC Cancer.
H. Olsson,
H. Kwon,
C. Ingvar,
2018,
Clinical and Translational Medicine.
D. Kleiner,
M. Dank,
M. Szász,
2019,
Biomedical Journal of Scientific & Technical Research.
G. Marko‐Varga,
M. Rezeli,
L. Betancourt,
2018,
Journal of proteome research.